Table 2.
Differentially Expressed Genes That Comprise Two of the Most Significantly Upregulated Canonical Pathways from Ingenuity Pathway Analysis
Gene name | Fold change | Adjusted p-value | IL-8 | NF-κB |
---|---|---|---|---|
Platelet-derived growth factor C | 1.66 | 0.008 | X | |
NF-κB inhibitor epsilon | 1.56 | 0.008 | X | |
Integrin subunit alpha 2b | 2.48 | 0.018 | X | |
Integrin subunit beta 3 | 2.46 | 0.018 | X | |
Integrin subunit beta 5 | 2.16 | 0.018 | X | X |
Epidermal growth factor | 1.93 | 0.022 | X | |
NF-κB subunit 2 | 1.34 | 0.027 | X | |
Ras homolog family member C | 1.41 | 0.049 | X | |
Intercellular adhesion molecule 1 | 1.35 | 0.060 | X | |
Insulin receptor substrate 1 | 1.68 | 0.063 | X | X |
Vascular endothelial growth factor A | 1.33 | 0.081 | X | |
Phosphoinositide-3-kinase regulatory subunit | 1.66 | 0.092 | X | X |
IL-8, interleukin-8 signaling; NF-κB, nuclear factor kappa B activation.